← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 9, 2021Last known activity
Jul 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (19 distinct, 9 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (10)
- NCT06926985Sponsor investigatorEarly Phase 1Jul 30, 2025
- NCT06926985Lead sponsorEarly Phase 1Jul 30, 2025
- NCT06904183CollaboratorPhase 2Apr 1, 2025
- NCT06158386CollaboratorPhase 2Nov 22, 2023
- NCT05848102CollaboratorPhase 4Dec 23, 2022
- NCT05603884CollaboratorPhase 2Dec 1, 2022
- NCT05520619CollaboratorPhase 2Sep 15, 2022
- NCT06827899CollaboratorPhase 2Jul 1, 2022
- NCT05305859CollaboratorPhase 2Apr 1, 2022
- NCT04718909CollaboratorPhase 2Jan 9, 2021
Details
- Last known activity
- Jul 30, 2025